| MicroRNAs as potential pharmaco-targets in ischemia-reperfusion injury compounded by diabetes H Dehaini, H Awada, A El-Yazbi, FA Zouein, K Issa, AA Eid, M Ibrahim, ... Cells 8 (2), 152, 2019 | 46 | 2019 |
| A comprehensive review of the genomics of multiple myeloma: Evolutionary trajectories, gene expression profiling, and emerging therapeutics H Awada, B Thapa, H Awada, J Dong, C Gurnari, P Hari, B Dhakal Cells 10 (8), 1961, 2021 | 21 | 2021 |
| Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M C Gurnari, N Gagelmann, A Badbaran, H Awada, D Dima, S Pagliuca, ... Leukemia 37 (3), 717-719, 2023 | 13 | 2023 |
| Knowledge, attitudes, and practices regarding drug interactions among community pharmacists N Makkaoui, A Halaoui, Z Atoui, H Siblini, S Habib, H Awada, NK Zgheib Journal of Public Health 29, 1357-1363, 2021 | 13 | 2021 |
| Personalized risk schemes and machine learning to empower genomic prognostication models in myelodysplastic syndromes H Awada, C Gurnari, A Durmaz, H Awada, S Pagliuca, V Visconte International Journal of Molecular Sciences 23 (5), 2802, 2022 | 12 | 2022 |
| Molecular patterns identify distinct subclasses of myeloid neoplasia T Kewan, A Durmaz, W Bahaj, C Gurnari, L Terkawi, H Awada, OD Ogbue, ... Nature communications 14 (1), 3136, 2023 | 8 | 2023 |
| Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia W Bahaj, T Kewan, C Gurnari, A Durmaz, B Ponvilawan, I Pandit, ... Journal of Hematology & Oncology 16 (1), 2023 | 7 | 2023 |
| Pancreatic cancer in the MENA region, a bibliometric review H Nassereldine, H Awada, AH Ali, M Zeineddine, ZA Sater, Y Shaib ecancermedicalscience 16, 2022 | 7 | 2022 |
| A focus on intermediate-risk acute myeloid leukemia: sub-classification updates and therapeutic challenges H Awada, MK Mustafa Ali, B Thapa, H Awada, L Seymour, L Liu, ... Cancers 14 (17), 4166, 2022 | 5 | 2022 |
| Prostate cancer in the Arab world: Bibliometric review and research priority recommendations AH Ali, H Awada, H Nassereldine, M Zeineddine, ZA Sater, A El-Hajj, ... Arab Journal of Urology 20 (2), 81-87, 2022 | 5 | 2022 |
| Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis with mucosal involvement following COVID-19 pneumonia H Ta, H Awada, P Kang, N Gilbert, N Haller, E Mostow, J Lane, I Singh Cureus 14 (11), 2022 | 4 | 2022 |
| Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting E Attardi, A Savi, B Borsellino, A Piciocchi, M Cipriani, T Ottone, E Fabiani, ... Blood Advances 7 (17), 5122-5131, 2023 | 3 | 2023 |
| High-grade large cell neuroendocrine carcinoma of the esophagus: a case report and review of the literature H Awada, A Hajj Ali, A Bakhshwin, H Daw Journal of Medical Case Reports 17 (1), 144, 2023 | 3 | 2023 |
| Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study B Fattizzo, C Gurnari, G Cassanello, M Bortolotti, H Awada, S Giammarco, ... Leukemia 37 (12), 2479-2485, 2023 | 2 | 2023 |
| OUTCOME PREDICTION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME UNDERGOING HEMATOPOIETIC CELL TRANSPLANT IN THE MOLECULAR ERA OF IPSS C Gurnari, N Gagelmann, A Badbaran, H Awada, D Dima, S Pagliuca, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 111-111, 2023 | 2 | 2023 |
| Endocrinopathies from checkpoint inhibitors: Incidence, outcomes, and management C Moc Cleveland Clinic Journal of Medicine 90 (5), 307, 2023 | 2 | 2023 |
| What’s Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach H Awada, C Gurnari, Z Xie, JP Bewersdorf, AM Zeidan Cancers 15 (8), 2248, 2023 | 2 | 2023 |
| A multimodal analysis of genomic and RNA splicing features in myeloid malignancies A Durmaz, C Gurnari, CE Hershberger, S Pagliuca, N Daniels, H Awada, ... Iscience 26 (3), 2023 | 2 | 2023 |
| The status of bladder cancer research worldwide, a bibliometric review and recommendations H Awada, AH Ali, MA Zeineddine, H Nassereldine, Z Abdul Sater, ... Arab Journal of Urology 21 (1), 1-9, 2023 | 2 | 2023 |
| Clinico-Molecular Risk Factors and Management of Thrombosis in a Large Real-Life Cohort of Patients with Paroxysmal Nocturnal Hemoglobinuria in the New Era of Anti-Complement … C Gurnari, H Awada, M Aly, D Dima, F Ullah, N Kawashima, Y Kubota, ... Blood 140 (Supplement 1), 8513-8514, 2022 | 2 | 2022 |
